MV Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95K | Buy |
884
+53
| +6% | +$5.69K | 0.01% | 246 |
|
|
2025
Q1 | $83.8K | Buy |
831
+7
| +0.8% | +$706 | 0.01% | 255 |
|
|
2024
Q4 | $73.6K | Buy |
824
+6
| +0.7% | +$536 | 0.01% | 259 |
|
|
2024
Q3 | $68.5K | Buy |
818
+4
| +0.5% | +$335 | 0.01% | 270 |
|
|
2024
Q2 | $62.7K | Buy |
814
+96
| +13% | +$7.39K | 0.01% | 270 |
|
|
2024
Q1 | $49.2K | Buy |
718
+13
| +2% | +$890 | 0.01% | 296 |
|
|
2023
Q4 | $40.8K | Buy |
705
+68
| +11% | +$3.93K | 0.01% | 322 |
|
|
2023
Q3 | $33.6K | Buy |
637
+35
| +6% | +$1.85K | ﹤0.01% | 327 |
|
|
2023
Q2 | $32.6K | Buy |
602
+56
| +10% | +$3.03K | ﹤0.01% | 341 |
|
|
2023
Q1 | $27.3K | Buy |
546
+145
| +36% | +$7.26K | ﹤0.01% | 354 |
|
|
2022
Q4 | $18.6K | Buy |
401
+107
| +36% | +$4.95K | ﹤0.01% | 356 |
|
|
2022
Q3 | $11K | Buy |
294
+147
| +100% | +$5.5K | ﹤0.01% | 430 |
|
|
2022
Q2 | $5K | Sell |
147
-329
| -69% | -$11.2K | ﹤0.01% | 548 |
|
|
2022
Q1 | $21K | Buy |
476
+210
| +79% | +$9.27K | ﹤0.01% | 331 |
|
|
2021
Q4 | $11K | Sell |
266
-158
| -37% | -$6.53K | ﹤0.01% | 421 |
|
|
2021
Q3 | $18K | Buy |
424
+208
| +96% | +$8.83K | ﹤0.01% | 323 |
|
|
2021
Q2 | $9K | Buy |
216
+181
| +517% | +$7.54K | ﹤0.01% | 378 |
|
|
2021
Q1 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 338 |
|